Major Pharmaceutical Conferences and Courses: October to November 2023.
- Published in:
- Pharmaceutical Medicine, 2023, v. 37, n. 4, p. 335, doi. 10.1007/s40290-023-00488-6
- Publication type:
- Article
Works matching IS 11782595 AND DT 2023 AND VI 37 AND IP 4
Results: 8
1
2
Meaningful Within-Patient Change on the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ): Analysis of Phase III Clinical Trial Data of Daridorexant.
- Published in:
- Pharmaceutical Medicine, 2023, v. 37, n. 4, p. 291, doi. 10.1007/s40290-023-00484-w
- By:
- Publication type:
- Article
3
75th Annual Meeting of the American Academy of Neurology (AAN 2023).
- Published in:
- Pharmaceutical Medicine, 2023, v. 37, n. 4, p. 331, doi. 10.1007/s40290-023-00481-z
- By:
- Publication type:
- Article
4
Interpersonal Values of Patients Participating in Phase II–III Clinical Trials: Implications for Clinical Trial Representativeness.
- Published in:
- Pharmaceutical Medicine, 2023, v. 37, n. 4, p. 319, doi. 10.1007/s40290-023-00479-7
- By:
- Publication type:
- Article
5
Current Status and Challenges of Pharmacovigilance of Traditional Medicines in French-Speaking West African (UEMOA) Countries.
- Published in:
- Pharmaceutical Medicine, 2023, v. 37, n. 4, p. 305, doi. 10.1007/s40290-023-00478-8
- By:
- Publication type:
- Article
6
Embedding Patient-Centricity by Collaborating with Patients to Transform the Rare Disease Ecosystem.
- Published in:
- Pharmaceutical Medicine, 2023, v. 37, n. 4, p. 265, doi. 10.1007/s40290-023-00474-y
- By:
- Publication type:
- Article
7
Tackling Counterfeit Drugs: The Challenges and Possibilities.
- Published in:
- Pharmaceutical Medicine, 2023, v. 37, n. 4, p. 281, doi. 10.1007/s40290-023-00468-w
- By:
- Publication type:
- Article
8
The Central Role of Ethics in Medical Affairs Practice.
- Published in:
- Pharmaceutical Medicine, 2023, v. 37, n. 4, p. 275, doi. 10.1007/s40290-023-00477-9
- By:
- Publication type:
- Article